Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and Chemotherapy (original) (raw)

Journal of investigational allergology & clinical immunology: official organ of the International Association of Asthmology (INTERASMA) and Sociedad Latinoamericana de Alergia e Inmunología

View PDFchevron_right

General considerations on rapid desensitization for drug hypersensitivity - a consensus statement

M. Torres, Mariana Castells, J. Cernadas, P. Demoly

Allergy, 2010

View PDFchevron_right

Rapid subcutaneous desensitization for the management of local and systemic hypersensitivity reactions to etanercept and adalimumab in 12 patients

Şebnem Ataman

The journal of allergy and clinical immunology. In practice, 2015

View PDFchevron_right

Successful desensitization with chemotherapeutic drugs: a tertiary care center experience

Fuat Kalyoncu

European annals of allergy and clinical immunology, 2022

View PDFchevron_right

Same-Day Desensitization in Patients Who Experience Their First Reaction to a Platin Agent at the Oncology Day Unit: A Pilot Study to Safely Include This Technique Within the Multidisciplinary Pathways for the Diagnosis & Management of Hypersensitivity to Platin Agents

Ernesto Enrique

Frontiers in Allergy

View PDFchevron_right

A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents

Ricardo Madrigal-Burgaleta

J Allergy Clin Immunol Pract , 2019

View PDFchevron_right

Management and Preparedness for Infusion and Hypersensitivity Reactions

Heinz-josef Lenz

The Oncologist, 2007

View PDFchevron_right

Desensitization to Adalimumab: An Example of Repeated Desensitization to a Biological Agent

Ugur Musabak

Drug Safety - Case Reports, 2015

View PDFchevron_right

Management of the highly sensitized patient

Ilias Doxiadis

Current Opinion in Immunology, 2009

View PDFchevron_right

Rapid desensitization for hypersensitivity reactions to paclitaxel and docetaxel: a new standard protocol used in 77 successful treatments

Anna Feldweg

Gynecologic Oncology, 2005

View PDFchevron_right

Delabeling Patients from Chemotherapy and Biologics Allergy: Implementing Drug Provocation Testing

Ricardo Madrigal-Burgaleta

The Journal of Allergy and Clinical Immunology: In Practice, 2020

View PDFchevron_right

Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations

Mariana Castells

Frontiers in Immunology

View PDFchevron_right

Hypersensitivity to chemotherapeutics: a cross sectional study with 35 desensitisations

Gursel Cok

International journal of clinical oncology, 2014

View PDFchevron_right

Assessment of antihistamines and corticosteroids as premedication in rapid drug desensitization to paclitaxel: outcomes in 155 procedures

Ricardo Madrigal-Burgaleta

Journal of Allergy and Clinical Immunology: In Practice, 2017

View PDFchevron_right

Short-term Clinical Evaluation of Four Desensitizing Agents

Cornelius Bamise

The Journal of Contemporary Dental Practice, 2008

View PDFchevron_right

Successful desensitization protocol for hypersensitivity reaction probably caused by dabrafenib in a patient with metastatic melanoma: Table 1

Salim Hadad

Japanese Journal of Clinical Oncology, 2015

View PDFchevron_right

Trends in hypersensitivity drug reactions: more drugs, more response patterns, more heterogeneity

T. Fernandez

Journal of investigational allergology & clinical immunology, 2014

View PDFchevron_right

Clinical applications of drug desensitization in the Asia-Pacific region

Bernard Thong

Asia Pacific Allergy, 2011

View PDFchevron_right

Drug Desensitization in the Management of Hypersensitivity Reactions to Monoclonal Antibodies and Chemotherapy (original) (raw)

Related papers